STAAR Surgical Company (STAA)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 13,986 | 21,776 | 16,613 | 15,298 | 21,347 | 19,444 | 24,889 | 31,863 | 38,755 | 37,824 | 33,582 | 29,111 | 24,501 | 22,906 | 20,778 | 11,039 | 5,913 | 8,965 | 7,461 | 12,547 |
| Total stockholders’ equity | US$ in thousands | 397 | 428,122 | 409,103 | 392,788 | 385,954 | 378,595 | 353,697 | 338,924 | 336,112 | 320,132 | 299,307 | 276,317 | 258,558 | 249,108 | 234,622 | 214,176 | 197,222 | 186,392 | 174,674 | 164,967 |
| ROE | 3,522.92% | 5.09% | 4.06% | 3.89% | 5.53% | 5.14% | 7.04% | 9.40% | 11.53% | 11.82% | 11.22% | 10.54% | 9.48% | 9.20% | 8.86% | 5.15% | 3.00% | 4.81% | 4.27% | 7.61% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $13,986K ÷ $397K
= 3,522.92%
STAAR Surgical Company's Return on Equity (ROE) has shown some fluctuations over the specified time period.
The ROE started at a moderate level of 7.61% as of March 31, 2020, and experienced a slight decline to 4.27% by June 30, 2020. However, there was a slight improvement in the following quarters, reaching 9.48% by December 31, 2021.
Subsequently, there was a notable increase in ROE, with the ratio peaking at 11.82% by September 30, 2022. However, from that point onwards, there was a downward trend in ROE performance, dropping to 3.89% by March 31, 2024.
The significant outlier in the data appears to be the ROE figure of 3,522.92% reported for December 31, 2024, which seems incredibly high and out of line with the other values. This may be a data entry error that could skew the overall analysis.
Overall, STAAR Surgical Company's ROE has shown variability over the period, with some periods of improvement followed by declines. The company may need to focus on maintaining a consistent and sustainable ROE performance to ensure long-term profitability and shareholder value.
Peer comparison
Dec 31, 2024